Yang Tang,Li Yang,Xianglin Yuan. Treatment of aggressive pancreatic solid pseudo-papillary neoplasms with apatinib plus S-1 chemotherapy: A case report and literature review. Oncol Transl Med, 2018, 4: 219-221.
Treatment of aggressive pancreatic solid pseudo-papillary neoplasms with apatinib plus S-1 chemotherapy: A case report and literature review
Received:September 14, 2018  Revised:October 18, 2018
View Full Text  View/Add Comment  Download reader
KeyWord:solid pseudopapillary neoplasm; apatinib; S1; chemotherapy
Author NameAffiliationE-mail
Yang Tang Tongji Hospital affiliated with Tongji Medical College, Huazhong University of Science and Technology, Hankou District, Wuhan, Hubei Province, China tangyangtjmu@126.com 
Li Yang Tongji Hospital affiliated with Tongji Medical College, Huazhong University of Science and Technology, Hankou District, Wuhan, Hubei Province, China  
Xianglin Yuan Tongji Hospital affiliated with Tongji Medical College, Huazhong University of Science and Technology, Hankou District, Wuhan, Hubei Province, China Xlyuan1020@163.com 
Hits: 5558
Download times: 6387
Abstract:
      Solid pseudopapillary neoplasm (SPN) is a rare indolent pancreatic neoplasm that occurs mostly in females. Although the malignancy potential is quite limited for SPN, these tumors can sometimes be aggressive and lead to inferior prognosis for male patients. In this case report, we present a special case of a male patient with SPN who experienced an aggressive tumor expansion after two surgical resections. For further treatment, we decided to administer chemotherapy with apatinib and S-1, and subsequent CT/MRI tumor monitoring indicated satisfactory control of tumor expansion. The effectiveness of apatinib plus the S-1 regimen should be tested for more patients with SPN in the future.
Close